MARTHA SERVEN: Open Payments
NPI 1144299850 · BELLINGHAM, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$340 in 14 payments from 10 companies in 2025. Trend: 2023 $275 · 2024 $126 · 2025 $340
Food & beverage: $317Consulting: $23
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $139 |
| AstraZeneca Pharmaceuticals LP | 1 | $33 |
| Regeneron Healthcare Solutions, Inc. | 1 | $31 |
| Pharming Healthcare, Inc. | 1 | $25 |
| ADMA BioManufacturing LLC | 1 | $23 |
| PFIZER INC. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| CSL Behring | 1 | $15 |
| Amgen Inc. | 1 | $15 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: DUPIXENT, FASENRA, RUCONEST, PANZYGA, CUVITRU, Hizentra, TEZSPIRE, NUCALA.
Industry payments across WA — which companies pay providers there.
